Gabelli Funds LLC lifted its holdings in Rentokil Initial plc (NYSE:RTO - Free Report) by 18.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,500 shares of the company's stock after purchasing an additional 12,000 shares during the quarter. Gabelli Funds LLC's holdings in Rentokil Initial were worth $1,937,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Cape Investment Advisory Inc. grew its stake in shares of Rentokil Initial by 65.2% in the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock worth $38,000 after purchasing an additional 594 shares during the last quarter. CENTRAL TRUST Co boosted its position in shares of Rentokil Initial by 15,208.3% during the fourth quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock valued at $47,000 after buying an additional 1,825 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in Rentokil Initial by 486.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock valued at $49,000 after purchasing an additional 1,611 shares during the period. Cromwell Holdings LLC bought a new position in Rentokil Initial in the 4th quarter valued at $59,000. Finally, Blue Trust Inc. grew its stake in Rentokil Initial by 140.4% in the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock valued at $60,000 after purchasing an additional 1,403 shares during the period. Institutional investors own 9.91% of the company's stock.
Rentokil Initial Stock Performance
NYSE:RTO traded up $0.08 during trading hours on Thursday, reaching $22.67. The company had a trading volume of 161,939 shares, compared to its average volume of 764,165. The company has a current ratio of 1.04, a quick ratio of 0.96 and a debt-to-equity ratio of 0.75. Rentokil Initial plc has a 52 week low of $19.60 and a 52 week high of $34.07. The firm has a market cap of $11.44 billion, a price-to-earnings ratio of 15.00, a PEG ratio of 7.95 and a beta of 1.07. The firm's 50 day moving average price is $23.07 and its 200-day moving average price is $24.42.
Rentokil Initial Dividend Announcement
The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 4th will be issued a $0.3825 dividend. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, April 4th. Rentokil Initial's dividend payout ratio is 43.71%.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating on shares of Rentokil Initial in a research note on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy".
View Our Latest Analysis on Rentokil Initial
Rentokil Initial Company Profile
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Recommended Stories

Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.